Jelena et al. enrolled 189 participants with T2D and/or arterial hypertension (HT), and found that levels of galectin-3 were higher in patients with both T2D and HT, and correlated with left ventricular (LV) mass, indicating the potential role of Galectin-3 for early detection of myocardial structural and functional alterations [81]. This evidence concerns the gene LGALS3 and hematocrit.